Search

everythinglearnresearchcommunity

for

Search:↓

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

Masculine facial features may not reliably indicate heritable health, and more research is needed.

Estrogen replacement can improve skin health in menopausal women but doesn't reverse sun damage or prevent hair loss.

Estrogen loss during menopause worsens skin health, but hormone replacement therapy may improve it, though more research is needed.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Researchers created a fully functional, bioengineered skin system with hair from stem cells that successfully integrated when transplanted into mice.

New treatments for male hypogonadism are effective and should be personalized.

The conclusion is that certain scalp tissue changes are characteristic of lichen planopilaris, with mucinous perifollicular fibroplasia being a new feature for diagnosis.

After menopause, women lose a lot of skin collagen, but estrogen replacement might improve skin health.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Shrinking skin cancer increases the chance of cancer in nearby lymph nodes.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Some drugs may reduce prostatitis symptoms short-term with few side effects.

Oral retinoids can cause side effects ranging from mild to severe, including birth defects, and require careful monitoring and contraception.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.